Clene Competitors

Stocks . USA . 
Stock . Clene Inc
CLNN Stock  USD 4.04  0.05  1.22%   
Clene Inc competes with MacroGenics, Ovid Therapeutics, Coya Therapeutics, Oramed Pharmaceuticals, and Whitehawk Therapeutics; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Clene competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Clene to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Clene Correlation with its peers.

Clene vs Connect Biopharma Correlation

Good diversification

The correlation between Clene Inc and CNTB is -0.17 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Clene Inc and CNTB in the same portfolio, assuming nothing else is changed.

Moving against Clene Stock

  0.72BA BoeingPairCorr
  0.63AA Alcoa CorpPairCorr
  0.59WMT Walmart Common Stock Aggressive PushPairCorr
  0.57GNTX GentexPairCorr
  0.55INTC Intel Aggressive PushPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.204.0411.34
Details
Intrinsic
Valuation
LowRealHigh
0.193.8811.18
Details
Naive
Forecast
LowNextHigh
0.073.3910.70
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.035.326.61
Details

Clene Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Clene and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Clene and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Clene Inc does not affect the price movement of the other competitor.

High positive correlations

STTK
+ 0.91
WHWK
STTK
+ 0.89
ORMP
WHWK
+ 0.88
ORMP
CNTX
+ 0.83
MGNX
ZNTL
+ 0.82
ORMP
STTK
+ 0.81
ZNTL
  

High negative correlations

ZNTL
- 0.86
COYA
COYA
- 0.85
MGNX
ORMP
- 0.83
COYA
STTK
- 0.82
COYA
WHWK
- 0.79
COYA
CNTX
- 0.76
COYA

Risk-Adjusted Indicators

There is a big difference between Clene Stock performing well and Clene Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Clene's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MGNX  3.00  0.38  0.10  2.78  3.20 
(3.45)
 6.83 
(5.18)
 24.44 
OVID  4.20  0.27  0.06  0.16  4.92 
(5.32)
 9.20 
(9.09)
 36.13 
COYA  2.51 (0.28) 0.00  0.93  0.00 
 0.00 
 4.69 
(5.27)
 18.45 
ORMP  2.81  0.73  0.31  0.42  1.91 
(4.08)
 6.98 
(3.49)
 17.67 
WHWK  3.48  0.43  0.12  0.51  3.33 
(4.14)
 6.98 
(5.26)
 21.49 
CNTX  4.26  1.35  0.30  2.59  3.55 
(5.09)
 9.59 
(6.09)
 20.53 
ZNTL  4.89  1.28  0.28  0.76  3.89 
(7.06)
 17.36 
(6.68)
 48.58 
STTK  3.65  1.23  0.36  4.28  2.92 
(4.61)
 6.42 
(4.82)
 27.07 
PLRX  2.61 (0.55) 0.00 (7.82) 0.00 
 0.00 
 4.58 
(6.71)
 22.72 
CNTB  4.45  0.90  0.17 (0.41) 3.95 
(5.64)
 11.89 
(6.42)
 36.83 

Clene Competitive Analysis

The better you understand Clene competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Clene's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Clene's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CLNN MGNX OVID COYA ORMP WHWK CNTX ZNTL STTK PLRX
 1.22 
 4.04 
Clene
 4.37 
 1.75 
MacroGenics
 3.21 
 1.51 
Ovid
 1.94 
 4.74 
Coya
 0.89 
 3.40 
Oramed
 6.67 
 2.88 
Whitehawk
 9.20 
 2.37 
Context
 3.29 
 2.51 
Zentalis
 0.52 
 3.85 
Shattuck
 2.42 
 1.21 
Pliant
Market Volatility
(90 Days Market Risk)
Very risky
Dangerous
Extremely Dangerous
Moderately volatile
Relatively risky
Very risky
Dangerous
Dangerous
Risky
Very risky
Market Performance
(90 Days Performance)
Weakest
Fair
Mild
Weakest
Solid
Fair
Solid
Good
Solid
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Risky
Strong
High
Low
Small
Low
Fair
High
Low
Risky
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
3.49
3.3
16.94
N/A
21.01
N/A
14.64
9.61
9.46
7.69
Net Asset
27.34 M
261.65 M
92.17 M
44.35 M
155.28 M
70.32 M
98.13 M
430.34 M
91.05 M
396.95 M
Profit Margin
N/A
-0.59
N/A
N/A
21.93
-1.09
N/A
N/A
N/A
N/A
EBITDA
(33.69 M)
(57.37 M)
(57.77 M)
(17.2 M)
(14.87 M)
(64.63 M)
(29.91 M)
(186.17 M)
(76.74 M)
(205.16 M)
Operating Margin
-376.53
0.26
-94.87
-0.54
-6.51
-7.54
N/A
-5.68
-10.72
N/A
Current Valuation
62.5 M
12.7 M
98.54 M
68.12 M
2.3 M
(35.82 M)
150.14 M
(81.46 M)
174.05 M
(105.74 M)
Price To Book
7.83
1.82
2.49
3.58
0.67
0.81
3.1
0.62
2.63
0.37
Retained Earnings
(282.12 M)
(1.17 B)
(304.3 M)
(40.74 M)
(176.62 M)
(332.65 M)
(94.78 M)
(1.05 B)
(381.72 M)
(710.05 M)
Current Asset
N/A
342.38 M
74.21 M
N/A
31 M
N/A
N/A
N/A
N/A
N/A
Beta
0.68
1.52
0.22
0.26
1.19
0.69
1.91
1.75
1.54
1.37
Number Of Employees
75
341
23
8
8
22
12
166
44
171
Shares Outstanding
11.78 M
63.26 M
71.21 M
20.92 M
39.8 M
47.13 M
91.88 M
64.75 M
63.28 M
61.45 M
Cash Flow From Operations
(21.33 M)
(68.37 M)
(55.96 M)
(10.29 M)
(8.41 M)
(59.55 M)
(14.56 M)
(170.86 M)
(60.52 M)
(155.5 M)
Annual Yield
N/A
N/A
N/A
N/A
0.0731
N/A
N/A
N/A
N/A
N/A
Total Debt
20.84 M
37.46 M
14.76 M
4.77 M
372 K
833 K
219.38 K
42.65 M
3.41 M
60.19 M
Return On Equity
-17.38
-0.81
-0.6
-0.62
0.24
-0.14
-0.34
-0.49
-0.58
-0.64
Return On Asset
-0.56
-0.27
-0.29
-0.37
-0.0422
-0.54
-0.23
-0.25
-0.34
-0.33
Number Of Shares Shorted
752.82 K
4.04 M
4.82 M
844.39 K
408.59 K
780.85 K
516.15 K
4.83 M
2.2 M
3.75 M
Book Value Per Share
-1.21
1.06
0.63
1.63
4.98
3.34
0.8
3.5
1.48
3.26
Current Liabilities
N/A
23.29 M
5.13 M
N/A
4 M
N/A
N/A
N/A
N/A
N/A
Total Asset
27.34 M
261.65 M
92.17 M
44.35 M
155.28 M
70.32 M
98.13 M
430.34 M
91.05 M
396.95 M
Short Ratio
7.19
2.43
3.17
2.8
1.6
5.39
0.34
1.87
3.6
3.96
Target Price
31.86
3.4
4.05
16.07
3.25
4.5
5.57
5.31
7.25
3.25
Debt To Equity
N/A
0.16
0.1
N/A
0.006
N/A
0.002
0.099
0.023
0.11
Shares Owned By Institutions
17.32
58.5
33.67
24.52
23.21
67.19
75.67
58.99
59.32
84.39
Market Capitalization
48.17 M
115.76 M
111.09 M
97.3 M
134.29 M
127.25 M
239.8 M
157.34 M
244.89 M
74.35 M
Price To Earning
4.09
-4.54
1.11
N/A
-11.22
N/A
N/A
N/A
N/A
N/A
Price To Earnings To Growth
N/A
0.01
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
225.11
0.91
16.81
24.4
67.14
8.85
N/A
5.86
244.89
3071.82
Net Income
(39.4 M)
(66.97 M)
(26.43 M)
(14.88 M)
(19.06 M)
(63.69 M)
(26.73 M)
(165.87 M)
(75.41 M)
(210.3 M)
Earnings Per Share
-3.36
-1.15
-0.5
-1.11
0.99
-0.64
-0.25
-2.08
-0.99
-2.86
Shares Owned By Insiders
28.61
3.06
9.81
5.69
14.6
12.43
1.18
22.46
11.04
2.4
Revenue
342 K
148.34 M
566 K
3.55 M
N/A
25.98 M
N/A
67.42 M
5.72 M
N/A
Working Capital
5.87 M
161.96 M
45.42 M
40.48 M
137.54 M
44.21 M
95.15 M
333.34 M
70.3 M
329.05 M
Cash And Equivalents
16.23 M
133.74 M
152.37 M
N/A
133.91 M
N/A
42.92 M
455.22 M
214.24 M
163.6 M
Cash Per Share
0.22
2.18
2.16
N/A
3.45
N/A
2.69
7.99
5.09
3.36
Gross Profit
176 K
(55.85 M)
6.61 M
(9.74 M)
13 K
(73.45 M)
N/A
26.86 M
21.7 M
N/A
Day Typical Price
4.1
1.79
1.53
4.74
3.37
2.83
2.45
2.5
3.88
1.21
Accumulation Distribution
3604.12
25161.44
146268.0
10619.3
7842.47
24508.47
468056.0
86823.02
20939.87
0.064
Market Facilitation Index
0.0
N/A
N/A
0.0
0.0
0.0
N/A
N/A
0.0
0.08
Daily Balance Of Power
(0.20)
(0.73)
(0.38)
0.36
0.1667
0.6
(0.50)
0.2857
(0.07)
(0.38)
Period Momentum Indicator
(0.05)
(0.08)
(0.05)
0.09
0.03
0.18
(0.24)
0.08
(0.02)
(0.03)
Rate Of Daily Change
0.99
0.96
0.97
1.02
1.01
1.07
0.91
1.03
0.99
0.98
Day Median Price
4.13
1.81
1.54
4.75
3.36
2.8
2.49
2.5
3.9
1.21
Price Action Indicator
(0.11)
(0.1)
(0.05)
0.04
0.055
0.17
(0.24)
0.05
(0.06)
(0.01)
Relative Strength Index
33.04
53.96
47.83
43.44
61.43
57.47
70.45
54.93
54.65
40.68
Coefficient Of Variation
(546.14)
1077.99
1572.14
(1,170)
433.77
879.6
381.32
618.04
393.58
(663.18)
Mean Deviation
5.13
3.0
4.2
2.51
2.81
3.48
4.26
4.89
3.65
2.61
Jensen Alpha
(1.45)
0.3777
0.2691
(0.28)
0.733
0.434
1.35
1.28
1.23
(0.55)
Total Risk Alpha
(1.80)
0.1189
(0)
(0.51)
0.5968
0.2095
1.05
0.8299
0.9342
(0.77)
Sortino Ratio
N/A
0.1001
0.0577
N/A
0.307
0.1206
0.2982
0.2845
0.3552
N/A
Downside Variance
N/A
11.42
32.21
N/A
6.39
12.76
19.89
21.25
11.34
N/A
Standard Deviation
7.3
4.25
6.03
3.36
3.61
4.28
5.28
8.45
4.93
3.55
Kurtosis
1.65
5.44
2.37
2.34
0.176
0.3479
(0.30)
8.03
3.74
3.3
Potential Upside
7.41
6.83
9.2
4.69
6.98
6.98
9.59
17.36
6.42
4.58
Treynor Ratio
(0.63)
2.78
0.1637
0.9326
0.4221
0.5113
2.59
0.7649
4.28
(7.82)
Maximum Drawdown
38.74
24.44
36.13
18.45
17.67
21.49
20.53
48.58
27.07
22.72
Variance
53.36
18.04
36.35
11.31
13.03
18.32
27.92
71.42
24.27
12.63
Market Risk Adjusted Performance
(0.62)
2.79
0.1737
0.9426
0.4321
0.5213
2.6
0.7749
4.29
(7.81)
Risk Adjusted Performance
(0.13)
0.0763
0.0554
(0.05)
0.1769
0.0916
0.2008
0.1277
0.1947
(0.10)
Skewness
(0.80)
1.51
0.6165
(0.82)
0.7885
0.5795
0.3086
2.56
1.44
(0.95)
Semi Deviation
N/A
3.2
4.92
N/A
1.91
3.33
3.55
3.89
2.92
N/A
Information Ratio
(0.19)
0.0796
0.0544
(0.10)
0.2151
0.1007
0.2517
0.1552
0.2428
(0.17)
Value At Risk
(15.07)
(5.18)
(9.09)
(5.27)
(3.49)
(5.26)
(6.09)
(6.68)
(4.82)
(6.71)
Expected Short fall
N/A
(3.45)
(5.32)
N/A
(4.08)
(4.14)
(5.09)
(7.06)
(4.61)
N/A
Downside Deviation
N/A
3.38
5.68
N/A
2.53
3.57
4.46
4.61
3.37
N/A
Semi Variance
N/A
10.25
24.24
N/A
3.65
11.07
12.58
15.16
8.55
N/A

Clene Competition Performance Charts

Five steps to successful analysis of Clene Competition

Clene's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Clene Inc in relation to its competition. Clene's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Clene in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Clene's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Clene Inc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Clene position

In addition to having Clene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sector ETFs Thematic Idea Now

Sector ETFs
Sector ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 500 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Clene Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Clene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Clene Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Clene Inc Stock:
How To Invest In Clene
Details
Is Clene Stock a good investment?
Details
What is Clene's Net Worth?
Details
Top Sectors
View
Check out Clene Correlation with its peers.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Will Stock sector continue expanding? Could Clene diversify its offerings? Factors like these will boost the valuation of Clene. Projected growth potential of Clene fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Clene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Clene Inc requires distinguishing between market price and book value, where the latter reflects Clene's accounting equity. The concept of intrinsic value—what Clene's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Clene's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
It's important to distinguish between Clene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Clene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Clene's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY